Trans-Coronary Sinus Intra-Septal Radiofrequency Ablation (TIRA) for Hypertrophic Obstructive Cardiomyopathy: First-in-Human Results
No significant adverse events, such as arrhythmias or vascular injuries, were reported. These findings suggest that the TIRA device may be a safe and effective option for treating HOCM. However, further studies are required to confirm these results.
Authors
- Ji Soo Oh (ORCID: https://orcid.org/0000-0001-8992-0871)
- Su-Jin Jung (ORCID: https://orcid.org/0009-0008-6919-4700)
- Min Ku Chon (ORCID: https://orcid.org/0000-0003-0183-6996)
- Jae-Young Seo
- June‐Hong Kim (ORCID: https://orcid.org/0000-0003-0653-0929)
- Cheol-Min Lee (ORCID: https://orcid.org/0009-0002-7861-454X)
Institutions
- Busan Medical Center (KR)
- Ulsan University Hospital (KR)
- Pusan National University Yangsan Hospital (KR)
- Pusan National University (KR)
Publication Details
- Journal
- Biomedicines
- Published
- 2024-12-04
- DOI
- https://doi.org/10.3390/biomedicines12122762
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00